
HealthEquity (HQY) Stock Forecast & Price Target
HealthEquity (HQY) Analyst Ratings
Bulls say
HealthEquity is well-positioned to benefit from the growing trend of high-deductible healthcare plans, as seen in its strong fourth quarter and fiscal year results with growth in service revenue and total accounts. With investments in technology and security, the company aims to improve efficiency and reduce fraud, which is reflected in their strong cash flow and free cash flow. With strong growth in custodial revenue and raised guidance for the next fiscal year, HealthEquity has been rated as a Buy for its potential for future growth and improved financials.
Bears say
HealthEquity is experiencing strong growth in revenue and gross profit, driven by increased efficiency and a reduction in fraud costs. However, operating expenses are also on the rise, surpassing analyst estimates and potentially limiting profitability. The company is focusing on transformation and expanding its services to include a marketplace for various health solutions, but their reliance on HSAs may limit their long-term growth potential.
This aggregate rating is based on analysts' research of HealthEquity and is not a guaranteed prediction by Public.com or investment advice.
HealthEquity (HQY) Analyst Forecast & Price Prediction
Start investing in HealthEquity (HQY)
Order type
Buy in
Order amount
Est. shares
0 shares